Use of levosimendan and beta-adrenergic receptor antagonist...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/501 (2006.01) A61K 31/138 (2006.01) A61K 31/403 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 9/04 (2006.01)

Patent

CA 2450915

A combination therapy for the treatment of heart failure comprises administering a combination of levosimendan or a pharmaceutically acceptable salt thereof and a beta-adrenergic receptor antagonist to a patient. The combination synergistically reduces mortality in heart failure patients.

Cette invention concerne un polythérapie pour défaillances cardiaques consistant à administrer à un patient une combinaison de lévosimendane ou d'un sel paharmaceutiquement acceptable de lévosimendane et un antagoniste de récepteur bêta-adrénergique. Cette combinaison permet de réduire synergétiquement la mortalité chez des patients atteints de défaillances cardiaques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of levosimendan and beta-adrenergic receptor antagonist... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of levosimendan and beta-adrenergic receptor antagonist..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of levosimendan and beta-adrenergic receptor antagonist... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1590896

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.